ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

The safety of rituximab in pediatric nephrotic syndrome patients: a pharmacovigilance study of the FAERS database.

Yanfeng Si et al.PubMed ↗Publisher ↗

No numbers read from the abstract.